T1	Participants 90 123	advanced nasopharyngeal carcinoma
T2	Participants 273 317	patients with nasopharyngeal carcinoma (NPC)
T3	Participants 410 430	42 patients with NPC
T4	Participants 1315 1332	patients with NPC
T5	Participants 1862 1879	patients with NPC
